Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
EMBO J
2012 Mar 07;315:1109-22. doi: 10.1038/emboj.2011.487.
Show Gene links
Show Anatomy links
A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling.
Imajo M
,
Miyatake K
,
Iimura A
,
Miyamoto A
,
Nishida E
.
???displayArticle.abstract???
The Hippo signalling pathway has emerged as a key regulator of organ size, tissue homeostasis, and patterning. Recent studies have shown that two effectors in this pathway, YAP/TAZ, modulate Wnt/β-catenin signalling through their interaction with β-catenin or Dishevelled, depending on biological contexts. Here, we identify a novel mechanism through which Hippo signalling inhibits Wnt/β-catenin signalling. We show that YAP and TAZ, the transcriptional co-activators in the Hippo pathway, suppress Wnt signalling without suppressing the stability of β-catenin but through preventing its nuclear translocation. Our results show that YAP/TAZ binds to β-catenin, thereby suppressing Wnt-target gene expression, and that the Hippo pathway-stimulated phosphorylation of YAP, which induces cytoplasmic translocation of YAP, is required for the YAP-mediated inhibition of Wnt/β-catenin signalling. We also find that downregulation of Hippo signalling correlates with upregulation of β-catenin signalling in colorectal cancers. Remarkably, our analysis demonstrates that phosphorylated YAP suppresses nuclear translocation of β-catenin by directly binding to it in the cytoplasm. These results provide a novel mechanism, in which Hippo signalling antagonizes Wnt signalling by regulating nuclear translocation of β-catenin.
Angers,
The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation.
2006, Pubmed,
Xenbase
Angers,
The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation.
2006,
Pubmed
,
Xenbase
Baena-Lopez,
The tumor suppressor genes dachsous and fat modulate different signalling pathways by regulating dally and dally-like.
2008,
Pubmed
Barker,
Mining the Wnt pathway for cancer therapeutics.
2006,
Pubmed
Barker,
Identification of stem cells in small intestine and colon by marker gene Lgr5.
2007,
Pubmed
Blache,
SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes.
2004,
Pubmed
Camargo,
YAP1 increases organ size and expands undifferentiated progenitor cells.
2007,
Pubmed
Cao,
YAP regulates neural progenitor cell number via the TEA domain transcription factor.
2008,
Pubmed
Clevers,
Wnt/beta-catenin signaling in development and disease.
2006,
Pubmed
de Lau,
Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling.
2011,
Pubmed
Dong,
Elucidation of a universal size-control mechanism in Drosophila and mammals.
2007,
Pubmed
Edgar,
From cell structure to transcription: Hippo forges a new path.
2006,
Pubmed
Fujita,
Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
2001,
Pubmed
Funayama,
Embryonic axis induction by the armadillo repeat domain of beta-catenin: evidence for intracellular signaling.
1995,
Pubmed
,
Xenbase
Gao,
Dishevelled: The hub of Wnt signaling.
2010,
Pubmed
Goulev,
SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila.
2008,
Pubmed
Gyorffy,
Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples.
2009,
Pubmed
Halder,
Hippo signaling: growth control and beyond.
2011,
Pubmed
Harvey,
The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis.
2003,
Pubmed
Harvey,
The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network.
2007,
Pubmed
Heallen,
Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size.
2011,
Pubmed
Hong,
TAZ, a transcriptional modulator of mesenchymal stem cell differentiation.
2005,
Pubmed
Huang,
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP.
2005,
Pubmed
Jia,
The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis.
2003,
Pubmed
Justice,
The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation.
1995,
Pubmed
Kango-Singh,
Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila.
2002,
Pubmed
Korinek,
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.
1997,
Pubmed
Lai,
Control of cell proliferation and apoptosis by mob as tumor suppressor, mats.
2005,
Pubmed
Lakshman,
CD44 promotes resistance to apoptosis in murine colonic epithelium.
2005,
Pubmed
Lei,
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
2008,
Pubmed
Lian,
The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation.
2010,
Pubmed
Lyons,
Requirement of Wnt/beta-catenin signaling in pronephric kidney development.
2009,
Pubmed
,
Xenbase
Mariadason,
Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation.
2001,
Pubmed
Moon,
WNT and beta-catenin signalling: diseases and therapies.
2004,
Pubmed
Muncan,
Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc.
2006,
Pubmed
Nishioka,
The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass.
2009,
Pubmed
Nusse,
Wnt signaling in disease and in development.
2005,
Pubmed
Okamoto,
Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB.
2006,
Pubmed
Pan,
The hippo signaling pathway in development and cancer.
2010,
Pubmed
Pantalacci,
The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila.
2003,
Pubmed
Reid,
Integrative approach for prioritizing cancer genes in sporadic colon cancer.
2009,
Pubmed
Tapon,
salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines.
2002,
Pubmed
Udan,
Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway.
2003,
Pubmed
van der Flier,
Transcription factor achaete scute-like 2 controls intestinal stem cell fate.
2009,
Pubmed
Van der Flier,
The Intestinal Wnt/TCF Signature.
2007,
Pubmed
van de Wetering,
The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.
2002,
Pubmed
Varelas,
The Hippo pathway regulates Wnt/beta-catenin signaling.
2010,
Pubmed
Wei,
Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila.
2007,
Pubmed
Wu,
The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway.
2008,
Pubmed
Wu,
hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts.
2003,
Pubmed
Xu,
Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase.
1995,
Pubmed
Yamanaka,
JNK functions in the non-canonical Wnt pathway to regulate convergent extension movements in vertebrates.
2002,
Pubmed
,
Xenbase
Zhang,
The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control.
2008,
Pubmed
Zhao,
TEAD mediates YAP-dependent gene induction and growth control.
2008,
Pubmed
Zhao,
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.
2010,
Pubmed
Zhao,
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
2007,
Pubmed
Zhou,
Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.
2009,
Pubmed
